Drug Shortage Report for CABAZITAXEL FOR INJECTION
Report ID | 203175 |
Drug Identification Number | 02487497 |
Brand name | CABAZITAXEL FOR INJECTION |
Common or Proper name | CABAZITAXEL |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | CABAZITAXEL |
Strength(s) | 45MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 4.5ML |
ATC code | L01CD |
ATC description | PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS |
Reason for shortage | Requirements related to complying with good manufacturing practices. |
Anticipated start date | |
Actual start date | 2023-08-29 |
Estimated end date | 2023-11-17 |
Actual end date | 2023-11-20 |
Shortage status | Resolved |
Updated date | 2023-11-21 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v11 | 2023-11-21 | English | Compare |
v10 | 2023-11-20 | French | Compare |
v9 | 2023-11-20 | English | Compare |
v8 | 2023-10-30 | French | Compare |
v7 | 2023-10-30 | English | Compare |
v6 | 2023-10-16 | French | Compare |
v5 | 2023-10-16 | English | Compare |
v4 | 2023-08-30 | English | Compare |
v3 | 2023-08-29 | French | Compare |
v2 | 2023-08-29 | English | Compare |
v1 | 2023-08-29 | English | Compare |
Showing 1 to 11 of 11